Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Vago

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Nature|November 15, 2002
Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune responseCecilia Garlanda, Emilio Hirsch, Silvia Bozza, et al.
Annals of Neurology|December 10, 2013
Allogeneic hematopoietic stem cell transplantation for neuromyelitis opticaRaffaella Greco, Attilio Bondanza, Luca Vago, et al.
Frontiers in Immunology|June 4, 2026
The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemiaAlessandro Bruno, Francesca Lorentino, Matteo G Carrabba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2015
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem CellsNicoletta Cieri, Raffaella Greco, Lara Crucitti, et al.
Bone Marrow Transplantation|April 19, 2018
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWPRaffaella Greco, Fabio Ciceri, Maddalena Noviello, et al.
Bone Marrow Transplantation|February 6, 2022
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experienceSimona Piemontese, Lorenzo Lazzari, Annalisa Ruggeri, et al.
Transplantation and Cellular Therapy|June 4, 2021
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell TransplantRaffaella Greco, Francesca Lorentino, Serena Albanese, et al.
Nature Communications|March 8, 2023
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemiaMatteo Maria Naldini, Gabriele Casirati, Matteo Barcella, et al.
Therapeutic Advances in Hematology|June 24, 2022
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donorsCarmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al.
Blood|July 23, 2008
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantationLuca Vago, Barbara Forno, Maria Pia Sormani, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Nature|November 15, 2002
Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune responseCecilia Garlanda, Emilio Hirsch, Silvia Bozza, et al.
Annals of Neurology|December 10, 2013
Allogeneic hematopoietic stem cell transplantation for neuromyelitis opticaRaffaella Greco, Attilio Bondanza, Luca Vago, et al.
Frontiers in Immunology|June 4, 2026
The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemiaAlessandro Bruno, Francesca Lorentino, Matteo G Carrabba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2015
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem CellsNicoletta Cieri, Raffaella Greco, Lara Crucitti, et al.
Bone Marrow Transplantation|April 19, 2018
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWPRaffaella Greco, Fabio Ciceri, Maddalena Noviello, et al.
Bone Marrow Transplantation|February 6, 2022
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experienceSimona Piemontese, Lorenzo Lazzari, Annalisa Ruggeri, et al.
Transplantation and Cellular Therapy|June 4, 2021
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell TransplantRaffaella Greco, Francesca Lorentino, Serena Albanese, et al.
Nature Communications|March 8, 2023
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemiaMatteo Maria Naldini, Gabriele Casirati, Matteo Barcella, et al.
Therapeutic Advances in Hematology|June 24, 2022
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donorsCarmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al.
Blood|July 23, 2008
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantationLuca Vago, Barbara Forno, Maria Pia Sormani, et al.
Pageof 12